Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Assess the Utility of CA-4F in a Canadian Cardiology Setting

NCT05210010 is registered in ClinicalTrials.gov with Ensho Health Intelligent Systems Inc. as lead sponsor.

NCT NCT05210010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05210010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Assess the Utility of CA-4F in a Canadian Cardiology Setting
Lead sponsor
Ensho Health Intelligent Systems Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2021
Completion date
May 31, 2022
Enrollment
8 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

transthyretin amyloid cardiomyopathy ("attr-cm")